Michael J. Fox Foundation Awards For Parkinson’s Drug Development Research

Off to find Dr. Wustman and Dr. Clark to see what is going on with this!

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

The Michael J. Fox Foundation Awards $4.6 Million To 10 Industry Teams For Parkinson’s Drug Development Research
1/23/2007

Brandon Wustman, PhD, and Sean Clark, PhD, of Amicus Therapeutics will attempt to develop drugs that take advantage of a possible genetic link between Parkinson’s and Gaucher’s disease. Gaucher’s disease is an inherited deficiency of the enzyme glucocerebrosidase, which results in the buildup of a toxic substance in parts of the body including the spleen, liver and bones; carriers of the mutation for this disorder have a significantly elevated risk of developing PD. Drs. Wustman and Clark will test a compound known to stabilize glucocerebrosidase for its ability to block Parkinson’s and Gaucher’s pathology. They will also look for interactions between glucocerebrosidase and alpha-synuclein, a protein whose clumping is a hallmark of PD pathology.

Comments

  1. What a fantastic lead! I hope it pays off. Amicus sounds like a company, so they probably have a time to market. (University research can be a bit open-ended.) We’ll be keeping our fingers crossed in North Carolina for you.

    Cristina’s last blog post..In Good Hands

  2. This is so exciting. I’ve always admired him. He’s a great person all and all. Sending you well wishes and don’t forget to take care of Mommy 🙂

    Chronic Chick

    Chronic Chick Talk’s last blog post..Documenting Memories of a Lifetime

  3. This is sounding great! Michael J Fox is a wonderful man. He has PD, and instead of being depressed, he is trying to make a change in the world.

    Alisha’s last blog post..It’s Baby Picture Sunday!

  4. heather says:

    let me know if you need a hand emailing anyone or whatever!